Randomized trial of the effect of drug presentation on asthma outcomes: The American Lung Association Asthma Clinical Research Centers

Division of Pulmonary and Critical Care Medicine, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Md 21224, USA.
The Journal of allergy and clinical immunology (Impact Factor: 11.25). 08/2009; 124(3):436-44, 444e1-8. DOI: 10.1016/j.jaci.2009.05.041
Source: PubMed

ABSTRACT Information that enhances expectations about drug effectiveness improves the response to placebos for pain. Although asthma symptoms often improve with placebo, it is not known whether the response to placebo or active treatment can be augmented by increasing expectation of benefit.
The study objective was to determine whether response to placebo or a leukotriene antagonist (montelukast) can be augmented by messages that increase expectation of benefit.
A randomized 20-center controlled trial enrolled 601 asthmatic patients with poor symptom control who were assigned to one of 5 study groups. Participants were randomly assigned to one of 4 treatment groups in a factorial design (ie, placebo with enhanced messages, placebo with neutral messages, montelukast with enhanced messages, or montelukast with neutral messages) or to usual care. Assignment to study drug was double masked, assignment to message content was single masked, and usual care was not masked. The enhanced message aimed to increase expectation of benefit from the drug. The primary outcome was mean change in daily peak flow over 4 weeks. Secondary outcomes included lung function and asthma symptom control.
Peak flow and other lung function measures were not improved in participants assigned to the enhanced message groups versus the neutral messages groups for either montelukast or placebo; no differences were noted between the neutral placebo and usual care groups. Placebo-treated participants had improved asthma control with the enhanced message but not montelukast-treated participants; the neutral placebo group did have improved asthma control compared with the usual care group after adjusting for baseline difference. Headaches were more common in participants provided messages that mentioned headache as a montelukast side effect.
Optimistic drug presentation augments the placebo effect for patient-reported outcomes (asthma control) but not lung function. However, the effect of montelukast was not enhanced by optimistic messages regarding treatment effectiveness.

Download full-text


Available from: Susan J Bartlett, Jul 05, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Informing patients about medical treatments and their possible side effects is ethically and legally obligatory but may trigger negative expectations and nocebo-related side effects. This pilot study aims to investigate the effect of different informed consent procedures on treatment expectations for adjuvant breast cancer treatments (Study 1: endocrine therapy; Study 2: chemotherapy). Method: Using an experimental 2-factorial design, healthy women were informed about endocrine therapy (n = 60) or chemotherapy (n = 64) within a hypothetical scenario. Information was framed with or without treatment benefit information and delivered in a personalized or standardized interaction. Primary outcomes were necessity-concern beliefs about the treatment and side-effect expectations, secondary outcomes were decisional conflicts. Results: In Study 1, side-effect expectations (ηp2 = .08) and decisional conflicts (ηp2 = .07) were lower when framed treatment information was given. Providing personalized information resulted in more functional necessity-concern beliefs (ηp2 = .06) and lower decisional conflicts (ηp2 = .07). Personalizing and framing of information resulted in more functional necessity-concern beliefs (ηp2 = .10) and lower decisional conflicts. In Study 2, necessity-concern beliefs were more functional with framing (ηp2 = .06). Participants in the personalized groups reported lower decisional conflicts (ηp2 = .06). No differences in side-effect expectations were revealed. Conclusions: This is the first study to provide evidence for optimized treatment expectations through altered informed consent strategies. The results emphasize that framing and personalizing informed consent can positively influence treatment expectations and reduce decisional conflicts. However, generalizations are impaired by the study's pilot character. The potential to prevent nocebo responses in clinical practice should be analyzed. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
    Health Psychology 02/2015; DOI:10.1037/hea0000217 · 3.95 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Important differences between men and women with asthma have been demonstrated, with women describing more symptoms and worse asthma-related quality of life (QOL) despite having similar or better pulmonary function. While current guidelines focus heavily on assessing asthma control, they lack information about whether sex-specific approaches to asthma assessment should be considered. We sought to determine if sex differences in asthma control or symptom profiles exist in the well-characterized population of participants in the American Lung Association Asthma Clinical Research Centers (ALA-ACRC) trials. We reviewed baseline data from four trials published by the ALA-ACRC to evaluate individual item responses to three standardized asthma questionnaires: the Juniper Asthma Control Questionnaire (ACQ), the multi-attribute Asthma Symptom Utility Index (ASUI), and Juniper Mini Asthma Quality of Life Questionnaire (mini-AQLQ). In the poorly-controlled population, women reported similar overall asthma control (mean ACQ 1.9 vs. 1.8; p = 0.54), but were more likely to report specific symptoms such as nocturnal awakenings, activity limitations, and shortness of breath on individual item responses. Women reported worse asthma-related QOL on the mini-AQLQ (mean 4.5 vs. 4.9; p < 0.001) and more asthma-related symptoms with a lower mean score on the ASUI (0.73 vs. 0.77; p ≤ 0.0001) and were more likely to report feeling bothered by particular symptoms such as coughing, or environmental triggers. In participants with poorly-controlled asthma, women had outwardly similar asthma control, but had unique symptom profiles on detailed item analyses which were evident on evaluation of three standardized asthma questionnaires.
    Respiratory medicine 08/2013; 107(10). DOI:10.1016/j.rmed.2013.07.024 · 2.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We consider the problem of optimally scheduling an arriving job on a set of homogeneous single-server queues: (i) arriving jobs consist of a random number of tasks which can be executed independently of each other; (ii) a job is completed only after all of its component tasks have finished execution; and (iii) a central dispatcher schedules the tasks on the queues at job arrival instants using information on the number of tasks currently scheduled on each processor. In the case of two queues when task are exponentially distributed, we show that the individually optimal policy is a mixture of policies corresponding to sequential job execution (all tasks are scheduled on a single processor) and parallel scheduling (tasks are distributed among several queues in a manner that tends to equalize queue lengths). Under conditions that include the case of moderate to heavy loads, the individually optimal scheduler is shown to schedule tasks according to the sequential policy. The conclusions obtained in this special case hold generally for an arbitrary number of processors and general task service time distribution
    Decision and Control, 1993., Proceedings of the 32nd IEEE Conference on; 01/1994